Prognostic value of peripheral blood inflammatory cell subsets in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Xiuxin GaoYixiang LiuYanan TianChongyou RaoFei ShiHaiwei BuJingyi LiuYing ZhangWeichao ShanZhenjiang DingLixian SunPublished in: The Journal of international medical research (2021)
Peripheral blood inflammatory cell subsets can predict MACE in patients with ACS undergoing PCI. These cell subsets could be important laboratory markers for the prognosis and clinical treatment of these patients.
Keyphrases
- peripheral blood
- percutaneous coronary intervention
- single cell
- acute coronary syndrome
- cell therapy
- coronary artery disease
- acute myocardial infarction
- oxidative stress
- st segment elevation myocardial infarction
- end stage renal disease
- antiplatelet therapy
- coronary artery bypass grafting
- atrial fibrillation
- heart failure